Amphastar Pharmaceuticals, Inc. (AMPH)
USD 24.05
(2.06%)
USD 24.05
(2.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 644.39 Million | 498.98 Million | 437.76 Million | 349.84 Million | 322.35 Million | 294.66 Million |
| Cost of Revenue | 300.42 Million | 250.12 Million | 238.02 Million | 206.5 Million | 190.43 Million | 187.68 Million |
| Gross Profit | 343.96 Million | 248.86 Million | 199.73 Million | 143.34 Million | 131.92 Million | 106.98 Million |
| Operating Expenses | 154.13 Million | 141.36 Million | 129.85 Million | 132.38 Million | 131.96 Million | 115.6 Million |
| Selling, General and Administrative Expenses | 80.39 Million | 66.59 Million | 68.92 Million | 65.15 Million | 63.1 Million | 58.04 Million |
| Research and Development Expenses | 73.74 Million | 74.77 Million | 60.93 Million | 67.22 Million | 68.85 Million | 57.56 Million |
| Other Expenses | - | 8.54 Million | 14.25 Million | -6.31 Million | 60.26 Million | -1.3 Million |
| Cost and Expenses | 447.4 Million | 391.49 Million | 367.88 Million | 338.89 Million | 322.39 Million | 303.28 Million |
| Operating Income | 196.98 Million | 78.75 Million | 43.13 Million | -14.22 Million | -39 Thousand | -8.62 Million |
| Interest Expense | 27.15 Million | 1.84 Million | 885 Thousand | 374 Thousand | 119 Thousand | 243 Thousand |
| Income Tax Expense | 31.83 Million | 23.47 Million | 20.63 Million | 3.54 Million | 13.72 Million | -3.26 Million |
| Earnings before Tax | 171.35 Million | 116.04 Million | 84.13 Million | 4.63 Million | 60.22 Million | -9.92 Million |
| Net Income | 137.54 Million | 91.38 Million | 62.11 Million | 1.09 Million | 48.93 Million | -5.73 Million |
| Earnings Per Share Basic | 2.85 | 1.88 | 1.30 | 0.02 | 1.04 | -0.12 |
| Earnings Per Share Diluted | 2.60 | 1.74 | 1.25 | 0.02 | 0.98 | -0.12 |
| Weighted Average Shares Outstanding | 48.26 Million | 48.55 Million | 47.77 Million | 47.03 Million | 46.98 Million | 46.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 53 Million | 52.42 Million | 49.78 Million | 49.12 Million | 49.9 Million | 46.39 Million |
| Gross Margin | 0.53 | 0.50 | 0.46 | 0.41 | 0.41 | 0.36 |
| EBIT Margin | 0.37 | 0.22 | 0.16 | 0.03 | -0.00 | -0.03 |
| Profit Margin | 0.21 | 0.18 | 0.14 | 0.00 | 0.15 | -0.02 |
| EBITDA | 241.46 Million | 107.49 Million | 111.77 Million | 30.19 Million | 81.46 Million | 6.83 Million |
| Earnings Before Tax Margin | 0.31 | 0.16 | 0.10 | -0.04 | -0.00 | -0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 182.39 Million | 171.83 Million | 178.1 Million | 644.39 Million | 180.55 Million | 145.71 Million |
| Cost of Revenue | 90.34 Million | 84.54 Million | 84.53 Million | 300.42 Million | 72.15 Million | 72.97 Million |
| Gross Profit | 92.04 Million | 87.29 Million | 93.56 Million | 343.96 Million | 108.4 Million | 72.73 Million |
| Operating Expenses | 36.83 Million | 39.28 Million | 39.58 Million | 144.28 Million | 35.72 Million | 35.84 Million |
| Selling, General and Administrative Expenses | 22.29 Million | 25.04 Million | 21.73 Million | - | 19.06 Million | 18.99 Million |
| Research and Development Expenses | 14.53 Million | 14.23 Million | 17.84 Million | - | 16.66 Million | 16.84 Million |
| Other Expenses | 298 Thousand | 5.92 Million | -5.48 Million | -3.92 Million | -9.04 Million | -4.08 Million |
| Cost and Expenses | 127.17 Million | 123.82 Million | 124.12 Million | 444.7 Million | 107.87 Million | 108.81 Million |
| Operating Income | 55.21 Million | 48.01 Million | 53.98 Million | 199.68 Million | 72.67 Million | 36.89 Million |
| Interest Expense | 8.6 Million | -8.61 Million | 9.45 Million | 29.15 Million | 13.7 Million | -3.6 Million |
| Income Tax Expense | 12.29 Million | 4.12 Million | 4.67 Million | 31.83 Million | 14.02 Million | 6.38 Million |
| Earnings before Tax | 50.24 Million | 47.87 Million | 41.34 Million | 171.35 Million | 63.63 Million | 32.8 Million |
| Net Income | 37.94 Million | 43.17 Million | 36.16 Million | 137.54 Million | 49.22 Million | 26.12 Million |
| Earnings Per Share Basic | 0.78 | 0.90 | 0.75 | - | 1.01 | 0.54 |
| Earnings Per Share Diluted | 0.73 | 0.81 | 0.68 | - | 0.91 | 0.49 |
| Weighted Average Shares Outstanding | 48.9 Million | 48.21 Million | 47.95 Million | 48.26 Million | 48.7 Million | 48.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.04 Million | 53.01 Million | 53.01 Million | 53 Million | 53.92 Million | 53.1 Million |
| Gross Margin | 0.50 | 0.51 | 0.53 | 0.53 | 0.60 | 0.50 |
| EBIT Margin | 0.38 | 0.36 | 0.38 | - | 0.40 | 0.25 |
| Profit Margin | 0.21 | 0.25 | 0.20 | 0.21 | 0.27 | 0.18 |
| EBITDA | 69.36 Million | 61.97 Million | 67.76 Million | - | 72.67 Million | 36.89 Million |
| Earnings Before Tax Margin | 0.30 | 0.28 | 0.30 | 0.31 | 0.40 | 0.25 |
TETOF
BSKZF
PRO
027410
104700
MOS